KLRS
#3950
Kalaris Therapeutics, Inc. - Common Stock
4.0 3 USD
-0.02%
Market Price
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
-1.71%
Changement Mensuel
+33.00%
Evolution sur 6 mois
-60.08%
Changement Annuel
-60.61%
Clôture Précédente
4.1 0
Open
4.0 3
Low
4.0 3
High
4.0 3
Volume
6
Financials
- Market Capitalization 95.93 M
- Employee 20
- Founded 2019
- CEO N/A
- Website www.kalaristx.com
- Headquarter Delaware, United States
- FIGI BBG00P80SH34
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 3942 |  VRCA Verrica Pharmaceuticals Inc. - Common Stock | 5.69 USD | +12.23% | +23.16% | +8.59% | -5.48% | 97.75 M USD | ||
| 3946 |  CGTX Cognition Therapeutics, Inc. - Common Stock | 1.02 USD | -3.77% | +3.03% | +13.33% | -56.41% | 97.00 M USD | ||
| 3971 |  FBIO Fortress Biotech, Inc. - Common Stock | 2.77 USD | -1.07% | -2.12% | -17.56% | +1.84% | 92.38 M USD | ||
| 3972 |  ATRA Atara Biotherapeutics, Inc. - Common Stock | 9.20 USD | -0.54% | -3.87% | +12.47% | -37.63% | 92.35 M USD |